Crystal Market Research (CMR) render to you profound details in respect to leading participants, regions, application and type of the Insulin Delivery Devices Market which is estimated to encounter substantial growth over the forecast period 2018-2025.
The insulin delivery devices market is expected to be around $19 billion by 2025. The market will show tremendous growth due to increase in the number of diabetes patients owing to unhealthy lifestyle, increasing awareness about diabetic care, and technologically advanced insulin delivery devices. In addition to this, favorable reimbursement policies are set to further stimulate the market growth. However, high cost of the devices, hazards and risks associated with the drug delivery devices, and the complications associated when it comes to the delivery of insulin can hamper the market growth.
Major Key Players:
Some of the key players in the global insulin delivery devices market are Becton Dickinson and Company, Abbott, Novo Nordisk Pharmaceutical, Eli Lilly and Company, Medtronic, Sanofi, and Roche Holding AG. These companies are highly focused on the development of technologically advanced insulin delivery devices to sustain in this competitive market.
Regional Outlook and Trend Analysis:
North America dominated the global market in 2016, due to the increasing prevalence of diabetes owing to sedentary lifestyle in this region, high adoption of technologically advanced insulin delivery devices, and advanced healthcare infrastructure. Asia-Pacific is expected to be the fastest growing segment during the forecast period, due to presence of a large population base suffering with diabetes, rising awareness amongst individuals, growing adoption of insulin pens because of improving healthcare expenditure and disposable income of people.
Get Premium Sample Copy at: https://www.crystalmarketresearch.com/report-sample/HC0623 .
Product Outlook and Trend Analysis:
Insulin pens accounted for the largest share of the insulin delivery devices market in 2016, due to rising number of diabetes patients, increasing adoption of insulin pens due to user-friendly design, and favorable reimbursement policies. Insulin pumps segment is expected to grow at the highest CAGR during the forecast period due to the increasing prevalence of Type 1 diabetes and technological advancements in insulin pumps. Growing focus of manufacturers on developing innovative and technologically advanced products is further contributing to the rising demand for these pumps.
Insulin Delivery Devices Market Segmentation:
By Product: Insulin Syringes, Insulin Pens, Insulin Pumps & Insulin Injectors
By End User: Hospitals, Homecare & Others
By Region: North America: (U.S, Canada & Mexico), Europe: (Germany, France, UK, Italy, Spain & Rest of Europe), Asia-Pacific: (Japan, China, Australia, India, South Korea, Rest of Asia-Pacific) and Rest of the World: (Brazil, South Africa, Saudi Arabia, Turkey, United Arab Emirates & Others)
There is enormous opportunity for new and varied technologies for delivering better care across diabetes care continuum. Major players are committed for developing cluster of technologies at affordable rate that will deliver better outcomes to patients. Manufacturers are focusing on mergers and partnership for developing new devices such as drug-device combination that will enhance diabetics care management and complications associated with diabetes.
Ask Questions to Expertise at: https://www.crystalmarketresearch.com/send-an-enquiry/HC0623 .
End User Outlook and Trend Analysis:
Homecare segment accounted for the largest share of the overall market in 2016 and is poised to grow at the highest CAGR during the forecast period. This is attributed to increasing diabetic population and increased adoption of insulin delivery devices by patients. Thus, ease of use and availability and accessibility of insulin delivery devices has made users to opt for insulin self-administration techniques.
Major ToC of Insulin Delivery Devices Market:
Part 1. Introduction
1.1. Report Description
1.2. Research Methodology
1.2.1. Secondary Research
1.2.2. Primary Research
Part 2. Executive Summary
2.1. Key Highlights
Part 3. Market Overview
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Share Analysis
3.3. Market Dynamics
188.8.131.52. Growing Prevalence of Diabetes
184.108.40.206. Increasing Awareness About Diabetic Care
220.127.116.11. Development of Technologically Advanced Insulin Delivery Devices
18.104.22.168. Favorable Reimbursement Policies
22.214.171.124. High Cost of the Devices
126.96.36.199. Hazards and Risks Associated with the Drug Delivery Devices
188.8.131.52. Complications Associated with the Delivery of Insulin
184.108.40.206. Inhalers toRevolutionize the Insulin Delivery Devices Market
3.4. Industry Trends
3.5. Reimbursement Scenario
…CONTINUED FOR TOC
(Early buyers will receive 10% customization on this report.)
Get Amazing Discount on Report at: https://www.crystalmarketresearch.com/check-discount/HC0623 .
About Crystal Market Research:
Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.
Crystal Market Research
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
Toll Free: +1-888-213-4282
Read Premium News from The Sat-PR at: https://www.satprnews.com/2018/06/21/international-insulin-delivery-devices-market-2018-estimated-to-be-around-usd-19-billion-competitive-key-players-detail-overview-by-key-segments-and-success-ratio-till-2025/ .